Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1295
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01466036 | Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors | ||
| NCT06543511 | MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies | ||
| NCT04720209 | Taking AIM at Breast Cancer | ||
| NCT04474626 | Isoquercetin in Sickle Cell Anemia | ||
| NCT02478164 | Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma | ||
| NCT03139331 | PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma | ||
| NCT01834183 | Tivozanib + Gemcitabine in Metastatic RCC | ||
| NCT05706766 | Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | ||
| NCT06795139 | Pilot of a Trial Enrollment Diversity Dashboard | ||
| NCT02919670 | A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma | ||
| NCT00588107 | A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors | ||
| NCT01415492 | Multiple Risk Behavior Intervention in Health Care Settings | ||
| NCT04906902 | Acalabrutinib in CNSL | ||
| NCT01523977 | Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL | ||
| NCT01398501 | Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant | ||
| NCT00633958 | A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors | ||
| NCT00137774 | Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors | ||
| NCT03325985 | Emergency Medicine Palliative Care Access | ||
| NCT07465276 | Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC | ||
| NCT02204085 | A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT01299038 | Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer | ||
| NCT02113878 | Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck | ||
| NCT03716180 | DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC | ||
| NCT07305740 | On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety | ||
| NCT00809250 | Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation | ||
| NCT03392090 | SHARE (Sharing Goals and Preferences) Study | ||
| NCT01009788 | ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer | ||
| NCT04339140 | Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer | ||
| NCT00098514 | Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors | ||
| NCT02777021 | Home Away From Home - Quality of Life Surveys | ||
| NCT03333616 | Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors | ||
| NCT05463848 | Surgical Pembro +/- Olaparib w TMZ for rGBM | ||
| NCT00379587 | Rituximab for Prevention of Chronic GVHD | ||
| NCT03637543 | Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer | ||
| NCT03447886 | Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds | ||
| NCT07147023 | Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication | ||
| NCT00903162 | Extended Endocrine Therapy for Premenopausal Women With Breast Cancer | ||
| NCT00842257 | Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer | ||
| NCT00936611 | LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia | ||
| NCT00684411 | Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma | ||
| NCT06138587 | Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation | ||
| NCT02576444 | OLAParib COmbinations | ||
| NCT03291730 | A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulatory Oncology Setting | ||
| NCT01596218 | Brentuximab Vedotin for Steroid Refractory GvHD | ||
| NCT03219450 | A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. | ||
| NCT01184326 | Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer | ||
| NCT01323920 | Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors | ||
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | ||
| NCT03316573 | Pembrolizumab in Neoplasms or Lymphomas | ||
| NCT00148720 | Capecitabine in Women With Operable Breast Cancer |
